|Day's Range||4.289 - 4.289|
|52 Week Range||4.289 - 8.531|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
RESEARCH TRIANGLE PARK, N.C., July 24, 2017-- BioCryst Pharmaceuticals, Inc. announced today that its second quarter 2017 financial results will be reported on Monday, August 7, 2017.. BioCryst will host ...
NEW YORK, NY / ACCESSWIRE / July 7, 2017 / U.S. markets continued to be dragged down by a selloff in technology stocks. The Dow Jones Industrial Average declined 0.74 percent to close at 21,320.04, while ...
NEW YORK, NY / ACCESSWIRE / June 15, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process ...